Suplatast tosilate is a drug used mainly in Japan to treat allergic conditions. It works by inhibiting the production of certain cytokines (like IL-4 and IL-5) from Th2 cells, which are involved in allergic reactions. This action helps to reduce inflammation and improve symptoms associated with allergic conditions. It is used in the management of bronchial asthma, atopic dermatitis, and allergic rhinitis. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Suplatast tosylate and Tosilate de suplatast. Its PubChem CID is 71773.
Suplatast tosilate
| CAS No | 94055-76-2 |
|---|---|
| Molecular Formula | C23H33NO7S2 |
| Molecular Weight | 499.6 g/mol |
| Synonyms | [3-[4-(3-ethoxy-2-hydroxypropoxy)anilino]-3-oxopropyl]-dimethylsulfanium;4-methylbenzenesulfonate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Suplatast tosilate is a drug used mainly in Japan to treat allergic conditions. It works by inhibiting the production of certain cytokines (like IL-4 and IL-5) from Th2 cells, which are involved in allergic reactions.
The listed CAS number is 94055-76-2.
The listed molecular formula is C23H33NO7S2.
The listed molecular weight is 499.6 g/mol.
[3-[4-(3-ethoxy-2-hydroxypropoxy)anilino]-3-oxopropyl]-dimethylsulfanium;4-methylbenzenesulfonate.
The source lists Suplatast tosylate and Tosilate de suplatast.